Skip to main content
. 2023 Jan 7;161(1):147–153. doi: 10.1007/s11060-022-04203-4

Table 1.

Median duration and interquartile range (IQR) of hematotoxicity grade 3 or 4 episodes

Lomustine-Temozolomide Temozolomide
n (%) Median duration (IQR) n (%) Median duration (IQR) p
Leukopenia 10 (15.2) 9 (6 – 16) 8 (12.7) 9 (6–21) 0.76
Neutropenia 8 (12.1) 10.5 (8 – 14.75) 4 (6.3) 11 (5–21.5) 0.95
Thrombopenia 19 (28.8) 13 (4.25–20.5) 15 (23.8) 14.5 (5.5–31.75) 0.46
Lymphopenia 3 (4.5) 140 (90 – n.d.) 4 (6.3) 7 (6.5–21.5) 0.024
Anemia 1 (1.5) 2 (n.d. – n.d.) 3 (4.8) 12.5 (1 – n.d.) 0.99